Odyssey Health, Inc. (OTCMKTS:ODYY) Sees Significant Decrease in Short Interest

Odyssey Health, Inc. (OTCMKTS:ODYY) was the target of a large decrease in short interest in the month of February. As of February 13th, there was short interest totaling 46,957 shares, a decrease of 26.3% from the January 29th total of 63,696 shares. Based on an average daily trading volume, of 157,277 shares, the short-interest ratio is presently 0.3 days. Based on an average daily trading volume, of 157,277 shares, the short-interest ratio is presently 0.3 days.

Odyssey Health Trading Down 12.9%

Shares of OTCMKTS:ODYY traded down $0.01 during midday trading on Tuesday, hitting $0.05. The company’s stock had a trading volume of 363,514 shares, compared to its average volume of 77,025. Odyssey Health has a fifty-two week low of $0.01 and a fifty-two week high of $0.13. The stock’s 50 day simple moving average is $0.05 and its 200 day simple moving average is $0.06.

Odyssey Health Company Profile

Odyssey Health, Inc, a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc Odyssey Health, Inc was incorporated in 2014 and is based in Las Vegas, Nevada.